Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells.
暂无分享,去创建一个
R. Gilbert | W. Qi | C. Pollock | S. Twigg | Xinming Chen | X. Chen | T. Polhill | Stephen M. Twigg | Carol A. Pollock | Richard E. Gilbert | Weier Qi
[1] R. Gilbert,et al. Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis. , 2005, American journal of physiology. Renal physiology.
[2] Yuan Zhang,et al. Intervention with Tranilast Attenuates Renal Pathology and Albuminuria in Advanced Experimental Diabetic Nephropathy , 2003, Nephron Physiology.
[3] T. Sugawara,et al. Tranilast Slows the Progression of Advanced Diabetic Nephropathy , 2002, Nephron.
[4] E. Robertis,et al. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β , 2002, Nature Cell Biology.
[5] M. Ward,et al. Tranilast Prevents Activation of Transforming Growth Factor-&bgr; System, Leukocyte Accumulation, and Neointimal Growth in Porcine Coronary Arteries After Stenting , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[6] J. Yates,et al. The Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor Is a Receptor for Connective Tissue Growth Factor* , 2001, The Journal of Biological Chemistry.
[7] H. Ochiai,et al. Tranilast inhibits TGF- A1 secretion without affecting its mRNA levels in conjunctival cells. , 2001, The Kobe journal of medical sciences.
[8] H. Yokoi,et al. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] T. Saruta,et al. Tranilast inhibits interleukin-1beta-induced monocyte chemoattractant protein-1 expression in rat mesangial cells. , 2001, European journal of pharmacology.
[10] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[11] T. Asano,et al. Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. , 2001, The Journal of urology.
[12] F. Strutz,et al. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). , 2001, Kidney international.
[13] W. B. Reeves,et al. Transforming growth factor β contributes to progressive diabetic nephropathy , 2000 .
[14] C. Pollock,et al. High glucose increases growth and collagen synthesis in cultured human tubulointerstitial cells , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[15] David W. Johnson,et al. Fibrogenic Effects of Cyclosporin A on the Tubulointerstitium: Role of Cytokines and Growth Factors , 1999, Nephron Experimental Nephrology.
[16] M. Murphy,et al. Connective tissue growth factor: a potential stimulus for glomerulosclerosis and tubulointerstitial fibrosis in progressive renal disease. , 1999, Current opinion in nephrology and hypertension.
[17] W. Qi,et al. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells , 1999, Diabetologia.
[18] McDonald,et al. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma , 1999, Histopathology.
[19] R. Baxter,et al. Paracrine stimulation of human renal fibroblasts by proximal tubule cells. , 1998, Kidney international.
[20] H. Miyata,et al. Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats. , 1998, Life sciences.
[21] M. Ward,et al. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries. , 1998, Atherosclerosis.
[22] R. Baxter,et al. Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis. , 1997, Kidney international.
[23] T. V. Kolesnikova,et al. Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. , 1997, Experimental cell research.
[24] W. Border,et al. TGF-β in kidney fibrosis: A target for gene therapy , 1997 .
[25] T. Nishikawa,et al. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. , 1994, Journal of Biochemistry (Tokyo).
[26] T. Yorifuji,et al. Treatment of linear localized scleroderma with the anti‐allergic drug, tranilast , 1994, Clinical and experimental dermatology.
[27] M. Ketteler,et al. Increased expression of transforming growth factor-beta in renal disease. , 1994, Current opinion in nephrology and hypertension.
[28] A. Koda,et al. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. , 1993, Japanese journal of pharmacology.
[29] M. Okuda,et al. A clinical evaluation of N-5' with perennial-type allergic rhinitis--a test by the multi-clinic, intergroup, double-blind comparative method. , 1984, Annals of allergy.
[30] A. Phillips,et al. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. , 2002, Histology and histopathology.
[31] D. Basile,et al. The transforming growth factor beta system in kidney disease and repair: recent progress and future directions. , 1999, Current opinion in nephrology and hypertension.
[32] K. Miyazawa,et al. Inhibitory effects of tranilast on proliferation, migration, and collagen synthesis of human vascular smooth muscle cells. , 1996, Canadian journal of physiology and pharmacology.
[33] J. Norman,et al. Cellular events in renal hypertrophy. , 1989, Annual review of physiology.